NLRP3 and Sepsis: Together, these observations suggest that inhibition of assembly of the NLRP3 inflammasome and release of the cardio-suppressive mediators IL-1β and IL-18 (67) contributes to the preservation of cardiac function afforded by baricitinib in sepsis.